The FDA will not approve a hantavirus vaccine before December 31, 2026. UTMB reported on June 25, 2026 promising animal results but those single-dose mRNA candidates that protected animals 100% against the Andes virus in The Lancet will not reach U.S. authorization this year despite Dr. Alexander B…